JP6999280B2 - 改善された複数の統合的効果を伴うコンタクトレンズ - Google Patents
改善された複数の統合的効果を伴うコンタクトレンズ Download PDFInfo
- Publication number
- JP6999280B2 JP6999280B2 JP2017054556A JP2017054556A JP6999280B2 JP 6999280 B2 JP6999280 B2 JP 6999280B2 JP 2017054556 A JP2017054556 A JP 2017054556A JP 2017054556 A JP2017054556 A JP 2017054556A JP 6999280 B2 JP6999280 B2 JP 6999280B2
- Authority
- JP
- Japan
- Prior art keywords
- eye
- contact lens
- graphic
- corneal
- design
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000694 effects Effects 0.000 title description 217
- 238000013461 design Methods 0.000 claims description 384
- 239000000049 pigment Substances 0.000 claims description 111
- 239000002932 luster Substances 0.000 claims description 72
- 239000010445 mica Substances 0.000 claims description 58
- 229910052618 mica group Inorganic materials 0.000 claims description 58
- 239000000463 material Substances 0.000 claims description 52
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 36
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000004408 titanium dioxide Substances 0.000 claims description 18
- 238000005538 encapsulation Methods 0.000 claims description 7
- SXQXMCWCWVCFPC-UHFFFAOYSA-N aluminum;potassium;dioxido(oxo)silane Chemical compound [Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O SXQXMCWCWVCFPC-UHFFFAOYSA-N 0.000 claims description 3
- 210000000695 crystalline len Anatomy 0.000 description 305
- 210000000554 iris Anatomy 0.000 description 154
- 239000010410 layer Substances 0.000 description 145
- 210000001508 eye Anatomy 0.000 description 99
- 239000003086 colorant Substances 0.000 description 58
- 239000002537 cosmetic Substances 0.000 description 52
- 239000000203 mixture Substances 0.000 description 50
- 238000000034 method Methods 0.000 description 48
- 238000007639 printing Methods 0.000 description 38
- 230000003287 optical effect Effects 0.000 description 31
- 230000001886 ciliary effect Effects 0.000 description 29
- 210000003786 sclera Anatomy 0.000 description 28
- 210000001747 pupil Anatomy 0.000 description 27
- 230000008569 process Effects 0.000 description 24
- 230000001179 pupillary effect Effects 0.000 description 23
- 230000004438 eyesight Effects 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 19
- 230000002093 peripheral effect Effects 0.000 description 19
- 230000007704 transition Effects 0.000 description 19
- 230000000007 visual effect Effects 0.000 description 18
- 238000002156 mixing Methods 0.000 description 16
- 210000003205 muscle Anatomy 0.000 description 16
- 229940067573 brown iron oxide Drugs 0.000 description 14
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 14
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 14
- 235000013980 iron oxide Nutrition 0.000 description 13
- NLAIHECABDOZBR-UHFFFAOYSA-M sodium 2,2-bis(2-methylprop-2-enoyloxymethyl)butyl 2-methylprop-2-enoate 2-hydroxyethyl 2-methylprop-2-enoate 2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O.CC(=C)C(=O)OCCO.CCC(COC(=O)C(C)=C)(COC(=O)C(C)=C)COC(=O)C(C)=C NLAIHECABDOZBR-UHFFFAOYSA-M 0.000 description 13
- 238000012937 correction Methods 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- 239000001034 iron oxide pigment Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 10
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 10
- 238000000576 coating method Methods 0.000 description 9
- 230000003278 mimic effect Effects 0.000 description 9
- -1 brown iron oxide Chemical compound 0.000 description 8
- 239000000017 hydrogel Substances 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- 239000002356 single layer Substances 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000004040 coloring Methods 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000004087 cornea Anatomy 0.000 description 6
- 208000016339 iris pattern Diseases 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 5
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- KIWATKANDHUUOB-UHFFFAOYSA-N propan-2-yl 2-hydroxypropanoate Chemical compound CC(C)OC(=O)C(C)O KIWATKANDHUUOB-UHFFFAOYSA-N 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 201000009310 astigmatism Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 239000001023 inorganic pigment Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000012860 organic pigment Substances 0.000 description 4
- 238000007649 pad printing Methods 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 3
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020675 Hypermetropia Diseases 0.000 description 3
- 229910010413 TiO 2 Inorganic materials 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 201000006318 hyperopia Diseases 0.000 description 3
- 230000004305 hyperopia Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 2
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 2
- 102100040409 Ameloblastin Human genes 0.000 description 2
- 101000891247 Homo sapiens Ameloblastin Proteins 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 201000000351 arcus senilis Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 2
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920002120 photoresistant polymer Polymers 0.000 description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- CGLVZFOCZLHKOH-UHFFFAOYSA-N 8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo(3,2-b:3',2'-m)triphenodioxazine Chemical compound CCN1C2=CC=CC=C2C2=C1C=C1OC3=C(Cl)C4=NC(C=C5C6=CC=CC=C6N(C5=C5)CC)=C5OC4=C(Cl)C3=NC1=C2 CGLVZFOCZLHKOH-UHFFFAOYSA-N 0.000 description 1
- 206010058646 Arcus lipoides Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000030374 Pupillary disease Diseases 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000008303 aniridia Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/021—Lenses; Lens systems ; Methods of designing lenses with pattern for identification or with cosmetic or therapeutic effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00317—Production of lenses with markings or patterns
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00865—Applying coatings; tinting; colouring
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/046—Contact lenses having an iris pattern
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/049—Contact lenses having special fitting or structural features achieved by special materials or material structures
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Eyeglasses (AREA)
- Prostheses (AREA)
Description
(1) 眼強調コンタクトレンズであって、
目の強膜領域に対応する第1の領域と、
目の角膜縁領域に対応する第2の領域と、
目の虹彩領域に対応する第3の領域と、
目の前記角膜縁領域に対応する前記第2の領域内に組み込まれ、かつ光沢のある輝く虹色の外観を有する角膜縁領域を形成するように構成された雲母ベースの真珠光沢顔料と、を含む、眼強調コンタクトレンズ。
(2) 前記雲母ベースの真珠光沢顔料には酸化物層がコーティングされている、実施態様1に記載の眼強調コンタクトレンズ。
(3) 前記酸化物層には二酸化チタンが含まれている、実施態様2に記載の眼強調コンタクトレンズ。
(4) 前記酸化物層には酸化鉄が含まれている、実施態様2に記載の眼強調コンタクトレンズ。
(5) 前記酸化物層にはケイ酸アルミニウムカリウムが含まれている、実施態様2に記載の眼強調コンタクトレンズ。
(7) 前記雲母ベースの真珠光沢顔料は非ランダムパターンで配列されている、実施態様1に記載の眼強調コンタクトレンズ。
(8) 前記第1、第2、及び第3の領域を覆う環形状の透明なコート層を更に含む、実施態様1に記載の眼強調コンタクトレンズ。
(9) 前記環形状の透明なコート層と、前記第1、第2、及び第3の領域との両方を覆うバルクレンズ材料を更に含む、実施態様8に記載の眼強調コンタクトレンズ。
(10) 前記第1の領域は第1のデザイングラフィックを含む、実施態様1に記載の眼強調コンタクトレンズ。
(12) 前記第3の領域は第3のデザイングラフィックを含む、実施態様1に記載の眼強調コンタクトレンズ。
(13) 前記強膜領域に対応する前記第1の領域内に組み込まれ、かつ光沢のある輝く虹色の外観を有する強膜領域を形成するように構成された雲母ベースの真珠光沢顔料を更に含む、実施態様1に記載の眼強調コンタクトレンズ。
(14) 前記虹彩領域に対応する前記第3の領域内に組み込まれ、かつ光沢のある輝く虹色の外観を有する虹彩領域を形成するように構成された雲母ベースの真珠光沢顔料を更に含む、実施態様1に記載の眼強調コンタクトレンズ。
(15) 眼強調コンタクトレンズであって、
目の強膜領域に対応する第1の領域と、
目の角膜縁領域に対応する第2の領域と、
目の虹彩領域に対応する第3の領域と、
前記第1、第2、及び第3の領域内に組み込まれ、かつ光沢のある輝く虹色の外観を有する強膜領域、角膜縁領域、及び虹彩領域を形成するように構成された雲母ベースの真珠光沢顔料と、を含む、眼強調コンタクトレンズ。
(17) 眼強調コンタクトレンズであって、
目の強膜領域に対応する第1の領域と、
目の角膜縁領域に対応する第2の領域と、
目の虹彩領域に対応する第3の領域と、
前記第1、第2、及び第3の領域のうちの少なくとも1つに組み込まれた雲母ベースの真珠光沢顔料であって、不透明で、光沢のある輝く虹色の外観の両方を形成する乳白剤として構成された、雲母ベースの真珠光沢顔料と、を含む、眼強調コンタクトレンズ。
Claims (13)
- 眼強調コンタクトレンズであって、
目の強膜領域に対応する第1の領域と、
目の角膜縁領域に対応する第2の領域と、
目の虹彩領域に対応する第3の領域と、
前記目の角膜縁領域に対応する前記第2の領域内に組み込まれ、かつ光沢のある輝く虹色の外観を有する角膜縁領域を形成するように構成された雲母ベースの真珠光沢顔料と、を含み、
前記第2の領域は、内側の境界及び外側の境界を備える黒い不透明な帯である角膜縁リングと、前記内側の境界と前記外側の境界との間に延在する、前記雲母ベースの真珠光沢顔料によって形成された封入リングと、前記内側の境界から前記眼強調コンタクトレンズの幾何学中心に向かって延びる、複数のランダムに配置された黒い不透明なテーパ状スポークとを含み、前記テーパ状スポークは、少なくとも部分的に前記第3の領域の一部を覆っており、前記封入リングは、前記外側の境界及び前記内側の境界から離間して位置している、眼強調コンタクトレンズ。 - 前記雲母ベースの真珠光沢顔料には酸化物層がコーティングされている、請求項1に記載の眼強調コンタクトレンズ。
- 前記酸化物層には二酸化チタンが含まれている、請求項2に記載の眼強調コンタクトレンズ。
- 前記酸化物層には酸化鉄が含まれている、請求項2に記載の眼強調コンタクトレンズ。
- 前記雲母ベースの真珠光沢顔料にはケイ酸アルミニウムカリウムが含まれている、請求項2に記載の眼強調コンタクトレンズ。
- 前記雲母ベースの真珠光沢顔料はランダムパターンで配列されている、請求項1に記載の眼強調コンタクトレンズ。
- 前記雲母ベースの真珠光沢顔料は非ランダムパターンで配列されている、請求項1に記載の眼強調コンタクトレンズ。
- 前記第1、第2、及び第3の領域を覆う環形状の透明なコート層を更に含む、請求項1に記載の眼強調コンタクトレンズ。
- 前記環形状の透明なコート層と、前記第1、第2、及び第3の領域との両方を覆うバルクレンズ材料を更に含む、請求項8に記載の眼強調コンタクトレンズ。
- 前記第1の領域は第1のデザイングラフィックを含む、請求項1に記載の眼強調コンタクトレンズ。
- 前記第3の領域は第3のデザイングラフィックを含む、請求項1に記載の眼強調コンタクトレンズ。
- 前記複数のランダムに配置された黒い不透明なテーパ状スポークはそれぞれ異なる形状及びサイズであり、前記テーパ状スポーク間の空間は透明である、請求項1に記載の眼強調コンタクトレンズ。
- 前記黒い不透明な帯の幅は1mmである、請求項12に記載の眼強調コンタクトレンズ。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021183315A JP7282859B2 (ja) | 2016-03-22 | 2021-11-10 | 改善された複数の統合的効果を伴うコンタクトレンズ |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/076,912 US20170276959A1 (en) | 2016-03-22 | 2016-03-22 | Contact lens with improved, multiple and integrated effects |
US15/076,912 | 2016-03-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021183315A Division JP7282859B2 (ja) | 2016-03-22 | 2021-11-10 | 改善された複数の統合的効果を伴うコンタクトレンズ |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017173824A JP2017173824A (ja) | 2017-09-28 |
JP6999280B2 true JP6999280B2 (ja) | 2022-01-18 |
Family
ID=58401437
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017054556A Active JP6999280B2 (ja) | 2016-03-22 | 2017-03-21 | 改善された複数の統合的効果を伴うコンタクトレンズ |
JP2021183315A Active JP7282859B2 (ja) | 2016-03-22 | 2021-11-10 | 改善された複数の統合的効果を伴うコンタクトレンズ |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021183315A Active JP7282859B2 (ja) | 2016-03-22 | 2021-11-10 | 改善された複数の統合的効果を伴うコンタクトレンズ |
Country Status (11)
Country | Link |
---|---|
US (2) | US20170276959A1 (ja) |
EP (1) | EP3223065A1 (ja) |
JP (2) | JP6999280B2 (ja) |
KR (1) | KR102413779B1 (ja) |
CN (1) | CN107219639A (ja) |
AU (1) | AU2017201822A1 (ja) |
BR (1) | BR102017005746A2 (ja) |
CA (1) | CA2961391A1 (ja) |
RU (1) | RU2670693C9 (ja) |
SG (1) | SG10201702253WA (ja) |
TW (2) | TWI722140B (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020138127A1 (ja) | 2018-12-28 | 2020-07-02 | ホヤ レンズ タイランド リミテッド | 眼鏡レンズ |
IT201900002339A1 (it) * | 2019-02-18 | 2020-08-18 | Thelios S P A | Metodo per realizzare una lente di occhiali rivestita mediante deposizione fisica di vapore pvd e corpo di supporto per uno sbozzato di lente |
USD899479S1 (en) * | 2019-03-21 | 2020-10-20 | Dae gon Kim | Contact lens |
USD899480S1 (en) * | 2019-03-21 | 2020-10-20 | Dae gon Kim | Contact lens |
USD899478S1 (en) * | 2019-03-21 | 2020-10-20 | Dae gon Kim | Contact lens |
US11891526B2 (en) * | 2019-09-12 | 2024-02-06 | Johnson & Johnson Vision Care, Inc. | Ink composition for cosmetic contact lenses |
US12055797B2 (en) * | 2019-10-31 | 2024-08-06 | Menicon Singapore Pte Ltd. | Contact lens with selective wavelength transmittance |
WO2021124120A1 (en) * | 2019-12-19 | 2021-06-24 | Alcon Inc. | Cosmetic contact lens for color blindness |
CA3192274A1 (en) * | 2020-09-10 | 2022-03-17 | May KLEINMAN BEN TSVI | Dry eye treatment system with disposable tip and corneal shield |
US11520166B2 (en) | 2020-09-24 | 2022-12-06 | Johnson & Johnson Vision Care, Inc. | Cosmetic contact lens with reversible effects |
AU2022247445A1 (en) * | 2021-03-29 | 2023-01-05 | Johnson & Johnson Vision Care, Inc. | Contact lens with improved cosmesis |
CN113917705B (zh) * | 2021-09-09 | 2023-04-28 | 江西台德智慧科技有限公司 | 一种用于不同明暗环境的智能视觉交互系统及其控制方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013546027A (ja) | 2010-12-14 | 2013-12-26 | ノバルティス アーゲー | カラーコンタクトレンズ |
JP2015197679A (ja) | 2014-03-31 | 2015-11-09 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッドJohnson & Johnson Vision Care, Inc. | 真珠光沢の強膜を有するコンタクトレンズ |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723541A (en) * | 1993-06-16 | 1998-03-03 | Rasor Associates, Inc. | Ocular lens composition and method of formation |
US6165260A (en) * | 1999-03-30 | 2000-12-26 | Engelhard Corporation | Pearlescent pigments exhibiting color travel |
US6196683B1 (en) * | 1999-04-23 | 2001-03-06 | Wesley Jessen Corporation | Pearlescent contact lens |
AU5871500A (en) * | 1999-06-11 | 2001-01-02 | Sydney Hyman | Image making medium |
US7267846B2 (en) * | 1999-11-01 | 2007-09-11 | Praful Doshi | Tinted lenses and methods of manufacture |
US6827440B2 (en) * | 2000-01-03 | 2004-12-07 | Wesley Jessen Company | Colored contact lens with a more natural appearance |
US6634747B1 (en) * | 2000-06-07 | 2003-10-21 | Novartis Ag | Sample indicator lens |
US20040150787A1 (en) * | 2000-10-13 | 2004-08-05 | Niculas Corneliu Daniel | Contact lens with encapsulated light-reflective particles |
US20020167640A1 (en) * | 2000-12-22 | 2002-11-14 | Francis Charles Auxilium | Contact lens with opaque iris pattern |
US7278736B2 (en) * | 2004-02-25 | 2007-10-09 | Novartis Ag | Contact lenses imparting a vivacious appearance to the eye |
US7641336B2 (en) * | 2004-05-12 | 2010-01-05 | Johnson & Johnson Vision Care, Inc | Tinted contact lenses with combined limbal ring and iris patterns |
TWI551305B (zh) * | 2007-08-31 | 2016-10-01 | 諾華公司 | 相對黏稠封裝溶液之用途 |
US8317322B2 (en) * | 2010-02-04 | 2012-11-27 | Johnson & Johnson Vision Care, Inc. | Contact lens with brightly colored sclera |
MY157328A (en) * | 2010-07-29 | 2016-05-31 | Novartis Ag | Colored contact lenses and method of making the same |
KR101217833B1 (ko) * | 2010-11-05 | 2013-01-02 | 박화성 | 노즐분사방식 또는 패드코팅으로 샌드위치 패드프린팅에 의한 컬러 콘택트렌즈 및 그 제조방법 |
US8915590B2 (en) * | 2012-05-18 | 2014-12-23 | Johnson & Johnson Vision Care, Inc. | Contact lens with halo effect |
-
2016
- 2016-03-22 US US15/076,912 patent/US20170276959A1/en not_active Abandoned
-
2017
- 2017-03-17 AU AU2017201822A patent/AU2017201822A1/en not_active Abandoned
- 2017-03-17 RU RU2017108919A patent/RU2670693C9/ru active
- 2017-03-20 CA CA2961391A patent/CA2961391A1/en not_active Abandoned
- 2017-03-20 TW TW106109087A patent/TWI722140B/zh active
- 2017-03-20 TW TW110105104A patent/TWI789703B/zh active
- 2017-03-21 SG SG10201702253WA patent/SG10201702253WA/en unknown
- 2017-03-21 BR BR102017005746-1A patent/BR102017005746A2/pt not_active Application Discontinuation
- 2017-03-21 JP JP2017054556A patent/JP6999280B2/ja active Active
- 2017-03-21 EP EP17162149.3A patent/EP3223065A1/en not_active Withdrawn
- 2017-03-22 CN CN201710173874.0A patent/CN107219639A/zh active Pending
- 2017-03-22 KR KR1020170036058A patent/KR102413779B1/ko active IP Right Grant
-
2020
- 2020-03-20 US US16/824,960 patent/US20200218086A1/en not_active Abandoned
-
2021
- 2021-11-10 JP JP2021183315A patent/JP7282859B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013546027A (ja) | 2010-12-14 | 2013-12-26 | ノバルティス アーゲー | カラーコンタクトレンズ |
JP2015197679A (ja) | 2014-03-31 | 2015-11-09 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッドJohnson & Johnson Vision Care, Inc. | 真珠光沢の強膜を有するコンタクトレンズ |
Also Published As
Publication number | Publication date |
---|---|
SG10201702253WA (en) | 2017-10-30 |
RU2670693C9 (ru) | 2018-11-28 |
TW201809810A (zh) | 2018-03-16 |
TW202125048A (zh) | 2021-07-01 |
RU2017108919A (ru) | 2018-09-17 |
EP3223065A1 (en) | 2017-09-27 |
CN107219639A (zh) | 2017-09-29 |
TWI722140B (zh) | 2021-03-21 |
RU2017108919A3 (ja) | 2018-09-17 |
RU2670693C2 (ru) | 2018-10-24 |
KR20170110044A (ko) | 2017-10-10 |
AU2017201822A1 (en) | 2017-10-12 |
TWI789703B (zh) | 2023-01-11 |
JP2017173824A (ja) | 2017-09-28 |
US20170276959A1 (en) | 2017-09-28 |
CA2961391A1 (en) | 2017-09-22 |
US20200218086A1 (en) | 2020-07-09 |
JP7282859B2 (ja) | 2023-05-29 |
JP2022017554A (ja) | 2022-01-25 |
KR102413779B1 (ko) | 2022-06-29 |
BR102017005746A2 (pt) | 2017-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6999280B2 (ja) | 改善された複数の統合的効果を伴うコンタクトレンズ | |
JP6797536B2 (ja) | 美容用コンタクトレンズ内の環形状クリア層 | |
JP6716199B2 (ja) | 真珠光沢の強膜を有するコンタクトレンズ | |
JP6755693B2 (ja) | 多層パターンを持つコンタクトレンズ | |
JP2024515395A (ja) | 美容上改良されたコンタクトレンズ | |
JP2023542768A (ja) | リバーシブル効果を有する美容用コンタクトレンズ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200117 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210302 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210713 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211110 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20211110 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20211117 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20211130 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211222 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6999280 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |